1. Home
  2. ENHA vs MIST Comparison

ENHA vs MIST Comparison

Compare ENHA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enhanced Group Inc. Class A Common Stock

ENHA

Enhanced Group Inc. Class A Common Stock

N/A

Current Price

$7.10

Market Cap

114.5M

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

N/A

Current Price

$0.39

Market Cap

95.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENHA
MIST
Founded
N/A
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.5M
95.3M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
ENHA
MIST
Price
$7.10
$0.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
★ $22.33
$3.86
AVG Volume (30 Days)
211.6K
★ 1.9M
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$215.89
Revenue Next Year
$118.94
$157.01
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.36
52 Week High
$14.09
$3.06

Technical Indicators

Market Signals
Indicator
ENHA
MIST
Relative Strength Index (RSI) 57.45 31.20
Support Level $6.30 N/A
Resistance Level $14.09 $0.84
Average True Range (ATR) 1.29 0.08
MACD -0.25 -0.03
Stochastic Oscillator 32.89 8.97

Price Performance

Historical Comparison
ENHA
MIST

About ENHA Enhanced Group Inc. Class A Common Stock

Enhanced Group Inc develops and sells sports and performance-related products intended for use by athletes and consumers. Its offerings focus on products associated with physical performance, health, and recovery. Its two principal offerings include: (i) the Enhanced Games, a live, multi-sport competition platform designed to showcase both "Enhanced" and "Non-Enhanced" athletes pursuing world-record performances under medically supervised conditions; and (ii) Live Enhanced, a direct-to-consumer digital and clinician-guided wellness platform offering evidence-based protocols, supplements, and coaching for consumers seeking to improve health, longevity, and well-being. The majority of the company's revenue is derived from products associated with physical performance, health, and recovery.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Share on Social Networks: